Global Atrophic Scars Treatment Market To Be Dominated By North America During The Forecast Period

The global atrophic scars treatment market size was worth around USD 23.62 billion in 2022 and is predicted to grow to around USD 47.19 billion by 2030 with a compound annual growth rate (CAGR) of roughly 9.04% between 2023 and 2030.

An atrophic scar is known to develop when the skin fails to generate tissue correctly. These scars are indented in appearance, unlike other skin scars such as hypertrophic scars or keloids. The texture is influenced due to the healing process that takes place below the expected skin layer. Atrophic scars are most commonly associated with acne or chickenpox but they may also develop due to a mole removal process that the patient may have undergone. There are three main types of atrophic scars. Rolling scars are characterized by distinct edges and are located around the cheeks. Flat-bottomed type resembles scars that arise due to chickenpox and are known as boxcars scars. The final type is the icepick scars that appear as deep pores. The atrophic scars treatment industry deals with various treatment processes undertaken to treat skin issues either completely or partially.

This review is based on a report by Zion Market Research, titled "Atrophic Scars Treatment Market By Distribution Channel (Pharmacies & Drug Stores, Hospitals, E-Commerce, and Clinics & Dermatology Centers), By Product Type (Laser, Topical, Injectable, and Surface Treatment), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 – 2030"- Report at https://www.zionmarketresearch.com/report/atrophic-scars-treatment-market

The global atrophic scars market is projected to grow owing to the increasing number of people suffering from acne. They are caused due to the inflammation of acne blemishes and sometimes if the blemish contents spill into the surrounding tissue it may cause deeper scars. Several causes can trigger mild to severe forms of acne and it affects people of all genders across age groups. Factors such as poor diet, irregular sleep patterns, dirty makeup brushes, and stress are some of the most common reasons that lead to acne while hormonal disbalance remains a primary uncontrollable cause of acne. As per National Health Service (NHS), more than 95% of people between the age group of 11 to 30 years face acne-related concerns to some extent.

In addition to this, the changing lifestyle and overconsumption of unhealthy food such as fried products, fast food, and other items prepared in unhygienic conditions can also cause acne leaving scars when healing. Moreover, the growing accessibility to treatment including more intense methods such as laser techniques or simple application of topical creams has resulted in greater demand for atrophic scar treatments.

The atrophic scars treatment industry may face growth restrictions due to the high cost of treatment, especially derma fillers and laser surgeries. It can limit access to treatment for people with limited income. Additionally, the lack of healthcare infrastructure especially the availability of experienced dermatologists in rural and underdeveloped areas could further restrict market expansion. Social stigma and psychological factors surrounding atrophic scars play a crucial role in determining whether a person is comfortable with undergoing the treatment procedures.

The rising demand for personalized treatments and medicines could create better growth opportunities while the risk of potential side-effects may challenge market growth.

The global atrophic scars treatment market is segmented based on distribution channel, product type, and region.

Based on distribution channel, the global market is divided into pharmacies & drug stores, hospitals, e-commerce, and clinics & dermatology centers. The atrophic scars treatment industry registered the highest growth in the clinics & dermatology centers segment in 2022 since they are under the care of specialized healthcare professionals with multiple years of practical and theoretical knowledge on dealing with skin-related conditions. They are also better equipped with necessary testing and diagnostic medical tools and offer a wide range of services including the treatment of all scar forms. The efficiency rate of dermatologists as compared to other medical professions when treating skin conditions is higher. As per reports by IBISWorld, there are around 5324 registered dermatologists in the US as of 2023. The pharmacies and drug stores segment also generates considerable revenue due to the high demand for over-the-counter (OTC) medicines especially in the topical form.

Based on product type, the atrophic scars treatment industry is divided into laser, topical, injectable, and surface treatment. The highest segmental growth was registered in the laser treatments and injectable segments in 2022. The former method typically includes fractional laser resurfacing which is one of the most commonly conducted procedures for treating atrophic scars. It can help in improving texture, tone, and overall scar appearance. Moreover, it also promoted collagen production. The method is highly regarded for its ability to deliver with extreme precision as it can penetrate the deeper layers of the skin. Derma fillers are an example of an injectable treatment. The filler contains substances like hyaluronic acid which are injected into the scar which results in the plumping of depressed areas. There is a considerable market for topical medicines driven by extensive promotions and advertisements conducted by skincare-selling brands. A fact sheet published by Yale Medicine claims that nearly 25% of women in their 40s report having acne.

The global atrophic scars treatment market is projected to be dominated by North America led by the higher awareness rate among the general population about the availability of several medical treatments available in the market. Moreover, high disposable income, surging healthcare expenditure, and the presence of an overall developed and advanced medical care architecture are responsible for higher growth.

Europe may register significant revenue due to the presence of multiple pharmaceutical companies specially operating in the dermatology segment along with an increasing number of cosmetic product manufacturers advertising products that are claimed to treat acne scars or other forms of atrophic scars.

In Asia-Pacific, India, China, Japan, and South Korea are likely to register a high growth rate as the demand for aesthetic-enhancing procedures is on the rise. The presence of a rapidly expanding cosmetics industry and advancements in skincare technologies are also crucial to regional market expansion.

Recent Developments:

• In January 2023, Rox Anderson, the director of the Wellman Center for Photomedicine at Harvard Medical School, discussed the future of dermatology at the Maui Derm Hawaii 2023. During these sessions, the participants explored new devices and therapies that can enhance dermatology practices in the future
• In April 2022, Lancer Dermatology, a premium dermatology practice based in Beverly Hills, announced a partnership with Forefront Dermatology. The latter is the largest physician-led specialty group focusing on dermatological services in the US

Atrophic Scars Treatment Market: Competitive Analysis

The global atrophic scars treatment market is led by players like :

• Allergan (AbbVie)
• Galderma
• Merz Pharma
• Cynosure
• Syneron Candela
• Lumenis
• Cutera
• Sciton
• Alma Lasers
• Sinclair Pharma
• Suneva Medical
• Johnson & Johnson
• Bausch Health Companies
• Revance Therapeutics
• Endo International
• Sanofi
• Nestlé Skin Health
• Merck & Co.
• Smith & Nephew
• Integra Lifesciences
• Coloplast
• Medtronic
• Zimmer Biomet
• Stryker
• Misonix.

The global atrophic scars treatment market is segmented as follows:

By Distribution Channel

• Pharmacies & Drug Stores
• Hospitals
• E-Commerce
• Clinics & Dermatology Centers

By Product Type

• Laser
• Topical
• Injectable
• Surface Treatment

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com